FLT3 — Drug Target

All drugs that target FLT3 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

FLT3 inhibitor · Tyrosine kinase inhibitor

Phase 3 pipeline (2)

• CGT9486 · Cogent Biosciences, Inc. · FLT3 inhibitor · Oncology
  CGT9486 is a selective tyrosine kinase inhibitor that targets FLT3, a receptor implicated in acute myeloid leukemia and other hematologic malignancies.
• ICP-488 · Beijing InnoCare Pharma Tech Co., Ltd. · FLT3 inhibitor · Oncology
  ICP-488 is a tyrosine kinase inhibitor that targets FLT3 and other kinases involved in hematologic malignancies.

Phase 2 pipeline (1)

• AC220 · Therapeutic Advances in Childhood Leukemia Consortium · Tyrosine kinase inhibitor · Oncology
  Tyrosine kinase inhibitor